Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Danaher: 3Q Earnings Snapshot

10/22/2020 | 06:10am EST

WASHINGTON (AP) _ Danaher Corp. (DHR) on Thursday reported third-quarter net income of $883.5 million.

On a per-share basis, the Washington-based company said it had net income of $1.16. Earnings, adjusted for one-time gains and costs, came to $1.72 per share.

The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.37 per share.

The industrial and medical device maker posted revenue of $5.88 billion in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $5.52 billion.

Danaher shares have climbed 48% since the beginning of the year, while the Standard & Poor's 500 index has increased slightly more than 6%. The stock has climbed 64% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DHR at https://www.zacks.com/ap/DHR

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about DANAHER CORPORATION
11/24DANAHER : To Present At Evercore ISI HealthCONx Conference
PR
11/23DANAHER : Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antib..
PR
11/17DANAHER : to Present at Wolfe Research Healthcare Conference
AQ
11/16DANAHER : To Present At Wolfe Research Healthcare Conference
PR
11/11DANAHER : Releases 2020 Sustainability Report
AQ
11/10DANAHER : Releases 2020 Sustainability Report
PR
11/10DANAHER : Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries..
PR
10/27DANAHER : Cytiva strengthens support to diagnostics industry with new labs, serv..
AQ
10/23DANAHER : Reports Third Quarter 2020 Results
AQ
10/22DANAHER : 3Q Profit, Sales Rise
DJ
More news
Financials (USD)
Sales 2020 21 960 M - -
Net income 2020 3 387 M - -
Net Debt 2020 15 370 M - -
P/E ratio 2020 46,7x
Yield 2020 0,33%
Capitalization 155 B 155 B -
EV / Sales 2020 7,76x
EV / Sales 2021 6,65x
Nbr of Employees 60 000
Free-Float 74,1%
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | MarketScreener
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 251,45 $
Last Close Price 218,26 $
Spread / Highest target 28,3%
Spread / Average Target 15,2%
Spread / Lowest Target -36,8%
EPS Revisions
Managers
NameTitle
Rainer M. Blair President, Chief Executive Officer & Director
Steven M. Rales Chairman
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Walter G. Lohr Independent Director
Sector and Competitors